The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - Shares of ViroPharma soared by 25% on Friday as Bloomberg reported that the drug developer has hired Goldman Sachs to explore takeover offers following  interest … Continue Reading
Read nowLong Ideas - Targeted therapies are the oncologists’ precision tool in treating difficult cancers. Where early therapeutics like radiotherapy and chemotherapy tackle cancers by bombarding all rapidly dividing … Continue Reading
Read nowInsights - After the bell Monday evening XenoPort (XNPT) released results from three early studies of XP23829, the company’s novel fumaric acid ester compound and a prodrug of monomethyl … Continue Reading
Read nowLong Ideas - The Amarin (AMRN) run-up has been in full swing this month. Recall that in June, Mr. King outlined why he expected a robust run-up into the FDA … Continue Reading
Read nowInsights - On Wednesday shortly after the lunch hour, the FDA posted publicly a letter dated August 28 that was sent to MiMedx Group (MDXG), a developer … Continue Reading
Read nowLong Ideas - Editor’s note: This trade was sent to PropThink Premium members on Friday, August 30. Purchased Sept 28 calls were good for more than 70% by the close … Continue Reading
Read nowLong Ideas - ChemoCentryx (CCXI), which we originally recommended on August 5 as a play on upcoming Phase III data for the company’s lead drug candidate vercirnon, has … Continue Reading
Read now
